VBL
VBL Therapeutics’ shares plummet on Phase 3 glioblastoma failure
March 9, 2018Medical Communications, Research and Development VBL, VBL Therapeutics, glioblastoma, pharma, trial failure
Israeli drug development firm VBL Therapeutics has been left reeling after it announced that its lead oncology product ofranergene obadenovec, …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
